Benadryl has been associated with worse school performance and, in one small study, impaired people’s ability to drive more ...

Epinephrine now available in a nasal spray formulation (neffy) is being hailed as a way to diminish barriers to use, which is critical in emergency situations such as an anaphylactic reaction. The ...

The FDA approved neffy epinephrine nasal spray, and it was the top allergy/asthma story in 2024. Image: Adobe Stock “We commend the FDA's decision to approve neffy, ...

Doctors explain what nasal spray is right for you this spring. Share Copy Link. Copy {copyShortcut} to copy ... Nasacort 24HR Allergy Nasal Spray. Nasacort. amazon.com. $34.99. $24.42.

The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals ...

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at least 66 pounds. It should be available in the next few months.

FDA approves new nasal spray to treat potentially life-threatening allergic reactions 01:58. The Food and Drug Administration approved a nasal spray intended to treat severe allergic reactions on ...

The Asthma and Allergy Foundation of America (AAFA) said the nasal spray may remove some barriers that prevent people from using epinephrine, especially for children who may be afraid of needles.

While the nasal spray currently is approved for kids and adults weighing at least 66 lb, it's being studied in pediatric patients who weigh less, and could be available to this group next year.